common.study.topics.clinical

Patients with Moderate to Severe Plaque Psoriasis Registry

common.study.values.description

“A Registry of Patients With Moderate to Severe Plaque Psoriasis”

The main purpose of the current study will be to provide real - world evidence regarding the safety and effectiveness of secukinumab in the management of patients with moderate to severe chronic plaque psoriasis.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Recruiting patients only common.study.methods.is-healthy-yes

Drug - Secikinumab

participant.views.study.view.additional

participant.views.study.view.scientific-title

A Registry of Patients With Moderate to Severe Chronic Plaque Psoriasis in Canada and Latin AmErica (LACan)

common.study.values.clinical-trial-id

NCT02786186

participant.views.study.view.id

QeZGQa